Johnson Fistel, LLP, a shareholder rights law firm, is investigating potential claims on behalf of Qiagen N.V. (NYSE: QGEN) shareholders who may have suffered losses. The investigation focuses on whether the company and its officers violated federal securities laws.
Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The investigation follows a class action complaint alleging that Qiagen made false and misleading statements regarding its business and prospects.
Shareholders who purchased Qiagen securities and have losses are encouraged to contact Johnson Fistel to discuss their legal rights and potential recovery options. The deadline for lead plaintiff motions is set for a future date.
